TY - JOUR
T1 - Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients :
T2 - Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
AU - González-Juanatey, Carlos
AU - Anguita-Sánchez, Manuel
AU - Barrios, Vivencio
AU - Núñez-Gil, Iván
AU - Gómez-Doblas, Juan José
AU - Garcia-Moll, Xavier
AU - Lafuente-Gormaz, Carlos
AU - Rollán-Gómez, María Jesús
AU - Peral-Disdier, Vicente
AU - Martínez-Dolz, Luis
AU - Rodríguez-Santamarta, Miguel
AU - Viñolas, Xavier
AU - Soriano-Colomé, Toni
AU - Muñoz Aguilera, Roberto
AU - Plaza, Ignacio
AU - Curcio, Alejandro
AU - Orts-Soler, Ernesto
AU - Segovia, Javier
AU - Fanjul, Víctor
AU - Cequier, Ángel
PY - 2022
Y1 - 2022
N2 - Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study.
AB - Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study.
KW - Diabetes mellitus
KW - Coronary artery disease
KW - MACE
KW - Risk factors
KW - Electronic health records
KW - Natural language processing
U2 - 10.3390/jcm11206004
DO - 10.3390/jcm11206004
M3 - Article
C2 - 36294325
SN - 2077-0383
VL - 11
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 20
ER -